BRIEF published on 01/10/2025 at 13:05, 1 year 8 months ago Lumira Ventures Promotes Suman Rao to Principal Healthcare Innovation Venture Capital Lumira Ventures Suman Rao Principal Promotion
BRIEF published on 01/10/2025 at 13:05, 1 year 8 months ago Lumira Ventures promeut Suman Rao au poste de directeur Capital-risque Lumira Ventures Innovation Dans Le Domaine De La Santé Suman Rao Promotion Principale
PRESS RELEASE published on 01/10/2025 at 13:00, 1 year 8 months ago Lumira Ventures Announces Promotion of Suman Rao to Principal Lumira Ventures promotes Suman Rao, Ph.D., to Principal, recognizing her contributions to healthcare innovation. Read more about her journey and achievements Healthcare Innovation Venture Capital Lumira Ventures Biomedical Suman Rao
BRIEF published on 06/26/2024 at 13:05, 2 years 2 months ago Lumira Ventures Promotes Nikhil Thatte to Partner Promotion Life Sciences Lumira Ventures Healthcare Investment Nikhil Thatte
BRIEF published on 06/26/2024 at 13:05, 2 years 2 months ago Lumira Ventures promeut Nikhil Thatte comme partenaire Promotion Lumira Ventures Investissement Dans La Santé Sciences De La Vie Nikhil Thatte
PRESS RELEASE published on 06/26/2024 at 13:00, 2 years 2 months ago Lumira Ventures Announces Promotion of Nikhil Thatte to Partner Lumira Ventures promotes Nikhil Thatte to Partner in recognition of his exceptional contributions to healthcare innovation. Nikhil's strategic insights drive firm's success and partnerships Life Sciences Healthcare Innovation Lumira Ventures Investment Firm Nikhil Thatte
BRIEF published on 04/02/2024 at 13:05, 2 years 5 months ago Lumira Ventures Invests in Nocion Therapeutics to Advance Chronic Cough Treatment Lumira Ventures Nocion Therapeutics Chronic Cough Treatment Phase 2b Study Series B Financing
BRIEF published on 04/02/2024 at 13:05, 2 years 5 months ago Lumira Ventures investit dans Nocion Therapeutics pour faire progresser le traitement de la toux chronique Lumira Ventures Financement De Série B Nocion Thérapeutique Traitement De La Toux Chronique Étude De Phase 2b
PRESS RELEASE published on 04/02/2024 at 13:00, 2 years 5 months ago Lumira Ventures Announces Investment in Nocion Therapeutics to Revolutionize Chronic Cough Treatment Lumira Ventures invests in Nocion Therapeutics' Taplucanium for Chronic Cough treatment. Series B funding of $70M secured from leading investors Series B Funding Lumira Ventures Nocion Therapeutics Taplucanium Chronic Cough
BRIEF published on 03/07/2024 at 13:05, 2 years 6 months ago Lumira Ventures Celebrates Team Promotions Ahead of International Women's Day Healthcare Innovation Gender Equality International Women's Day Lumira Ventures Team Promotions
Published on 09/11/2026 at 14:30, 4 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 13:58, 36 minutes ago BlackBerry Radar Advances Asset Intelligence for Transportation
Published on 09/11/2026 at 13:00, 1 hour 34 minutes ago Silver Tiger Intersects 2.1 Metres of 7.72 Kilograms Per Tonne Silver Equivalent in the Caleigh Vein Including 0.53 Metres of 29.62 Kilograms
Published on 09/11/2026 at 04:00, 10 hours 34 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 16 hours 9 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/11/2026 at 13:48, 45 minutes ago Original-Research: Cantourage Group SE (von First Berlin Equity Research GmbH): Kaufen
Published on 09/11/2026 at 13:36, 57 minutes ago Vulcan secures second lithium production licence for Lionheart Project
Published on 09/11/2026 at 07:00, 7 hours 34 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 7 hours 34 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 7 hours 34 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 19 hours 4 minutes ago Availability of the 2026 Interim Financial Report
